Zura Bio Ltd
ZURA · XNASCIK 1855644fmd_0EFZXKG4BM2GS5V0T1VNQ4SCFZManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Mar 10, 2021 to Sep 30, 2026, 21 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Realized investment gains (losses) | 2 | – | – | – |
| Research and development | – | 44 | 24 | 42 |
| Total operating expenses | – | 63 | 55 | 75 |
| Operating income | (3) | (63) | (55) | (75) |
| Interest and investment income | 0 | 2 | 8 | 6 |
| Other non-operating income (expense) | 6 | 2 | 3 | 7 |
| Income before taxes | – | (61) | (52) | (69) |
| Income tax expense | – | 0 | 0 | – |
| Net income from continuing operations | – | (61) | (52) | – |
| Net income | (26) | (60) | (52) | (69) |
| Net income to common shareholders | – | (69) | (45) | (99) |